High Heterogeneity of Multidrug-Resistant Enterobacteriaceae Fecal Levels in Hospitalized Patients Is Partially Driven by Intravenous β-Lactams

Author:

Djukovic Ana1,González-Barberá Eva M.2,Sanz Jaime23,Artacho Alejandro1,Peñaranda Iván1,Herrera Beatriz1,Garzón María José1,Salavert Miguel2,López-Hontangas José Luis2,Xavier Karina B.4ORCID,Kuster Bernhard5,Debrauwer Laurent67,Rolain Jean-Marc8,Sanz Miguel A.23,Xavier Joao B.910,Ubeda Carles111

Affiliation:

1. Centro Superior de Investigación en Salud Pública—FISABIO, Valencia, Spain

2. Hospital Universitari i Politècnic La Fe, Valencia, Spain

3. CIBERONC, Instituto Carlos III, Madrid, Spain

4. Instituto Gulbenkian de Ciência, Oeiras, Portugal

5. Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany

6. Toxalim—Research Center in Food Toxicology, Toulouse University, INRA UMR 1331, ENVT, INP-Purpan, Paul Sabatier University, Toulouse, France

7. Axiom Platform, UMR 1331 Toxalim, MetaToul-MetaboHUB, National Infrastructure of Metabolomics and Fluxomics, Toulouse, France

8. Aix Marseille Univ, IRD, APHM, MEPHI, IHU—Méditerranée Infection, Marseille, France

9. Lucille Castori Center for Microbes, Inflammation and Cancer, Memorial Sloan Kettering Cancer Center, New York, New York, USA

10. Computational and Systems Biology Program, Sloan-Kettering Institute, New York, New York, USA

11. Centers of Biomedical Research Network (CIBER) in Epidemiology and Public Health, Madrid, Spain

Abstract

Multidrug-resistant Enterobacteriaceae (MRE) colonize the intestine asymptomatically from where they can breach into the bloodstream and cause life-threatening infections, especially in heavily colonized patients. Despite the clinical relevance of MRE colonization levels, we know little about how they vary in hospitalized patients and the clinical factors that determine those levels.

Funder

Consellería de d’Educació, Investigació, Cultura i Esport

Ministerio de Economía y Competitividad

MINECO | Instituto de Salud Carlos III

Bundesministerium für Bildung und Forschung

Fundação para a Ciência e a Tecnologia

HHS | National Institutes of Health

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3